182 related articles for article (PubMed ID: 25843190)
1. SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection.
Alghamdi AS; Alqutub A; Abaalkhail F; Sanai FM; Alghamdi H; Altraif I; Alswat KA; Alghamdi MY; Babatin MA; Alfaleh FZ
Saudi J Gastroenterol; 2015; 21(2):60-3. PubMed ID: 25843190
[No Abstract] [Full Text] [Related]
2. Hepatitis C position statement: Taking a stand and standing by it.
Sanai FM; Alghamdi AS; Alghamdi MY
Saudi J Gastroenterol; 2015; 21(4):262-3. PubMed ID: 26228373
[No Abstract] [Full Text] [Related]
3. Ribavirin-free treatment may soon be a reality.
Al-Judaibi B
Saudi J Gastroenterol; 2015; 21(4):260-1. PubMed ID: 26228372
[No Abstract] [Full Text] [Related]
4. Consensus guidelines for the management of hepatitis C infection.
Consensus Guidelines Committee for the Management of Hepatitis C Infection
Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
[TBL] [Abstract][Full Text] [Related]
5. SASLT guidelines: Update in treatment of Hepatitis C virus infection.
Alghamdi AS; Alghamdi M; Sanai FM; Alghamdi H; Aba-Alkhail F; Alswat K; Babatin M; Alqutub A; Altraif I; Alfaleh F
Saudi J Gastroenterol; 2016 Aug; 22 Suppl(Suppl 2):S25-57. PubMed ID: 27538727
[No Abstract] [Full Text] [Related]
6. Ribavirin: is it a mutagen for hepatitis C virus?
Perelson AS; Layden TJ
Gastroenterology; 2007 May; 132(5):2050-2. PubMed ID: 17484896
[No Abstract] [Full Text] [Related]
7. The importance of rapid viral suppression in the era of directly acting antiviral therapy for hepatitis C virus.
Jenkins ET; Jensen DM
Infect Dis Clin North Am; 2012 Dec; 26(4):879-91. PubMed ID: 23083821
[TBL] [Abstract][Full Text] [Related]
8. PSG consensus statement on management of hepatitis C virus infection--2003.
Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
[No Abstract] [Full Text] [Related]
9. Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C.
Ta K; Zehtabchi S
Am Fam Physician; 2017 Jun; 95(11):Online. PubMed ID: 28671433
[No Abstract] [Full Text] [Related]
10. Virology of hepatitis B and C viruses and antiviral targets.
Pawlotsky JM
J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
[TBL] [Abstract][Full Text] [Related]
12. Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals.
Ippolito G; Antonelli G
Clin Microbiol Infect; 2016 Oct; 22(10):824-825. PubMed ID: 27863749
[No Abstract] [Full Text] [Related]
13. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
Degos F
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S57-65. PubMed ID: 9161515
[No Abstract] [Full Text] [Related]
14. Current and future therapies for hepatitis C virus infection.
Ozaras R; Yemisen M; Balkan İİ
N Engl J Med; 2013 Aug; 369(7):679. PubMed ID: 23944319
[No Abstract] [Full Text] [Related]
15. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.
Bruchfeld A; Lindahl K; Stahle L; Schvarcz R
J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023
[No Abstract] [Full Text] [Related]
16. [Argentine consensus on hepatitis C 2013].
Reggiardo MV; Tanno F; Mendizabal M; Galdame O
Acta Gastroenterol Latinoam; 2014 Jun; 44(2):154-73. PubMed ID: 25199310
[No Abstract] [Full Text] [Related]
17. Treatment of acute hepatitis C-how to explain the differences?
Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
[No Abstract] [Full Text] [Related]
18. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
[No Abstract] [Full Text] [Related]
19. Hepatitis C virus infection in Taiwan: Past, present, and future.
Kao JH
J Formos Med Assoc; 2016 Feb; 115(2):65-6. PubMed ID: 26228687
[No Abstract] [Full Text] [Related]
20. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
Sarrazin C; Zeuzem S
Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
